drugset / Trial / NCT01050127

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

NCT01050127

Phase 1 Completed 36 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

The objectives of this study are to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of multiple doses of ABT-436 in healthy adults.

Timeline

Start
2009-12
Primary completion
2010-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject ABT-436 Unknown

Indications

No indication recorded.